Hualan Biological Bacterin Inc. (301207.SZ)
CNY 18.51
(0.16%)
CNY 18.51
(0.16%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -340.98 Million CNY | -13.71% |
| 2022 | -299.85 Million CNY | -180.89% |
| 2021 | 370.7 Million CNY | 274.54% |
| 2020 | -212.38 Million CNY | 23.79% |
| 2019 | -278.69 Million CNY | -94.87% |
| 2018 | -143.01 Million CNY | -437.92% |
| 2017 | -26.58 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -950.47 Million CNY | -193.37% |
| 2024 Q1 | -323.99 Million CNY | 4.98% |
| 2024 Q3 | -224.34 Million CNY | 76.4% |
| 2023 Q3 | -75.78 Million CNY | 82.55% |
| 2023 FY | -340.98 Million CNY | -13.71% |
| 2023 Q4 | -340.98 Million CNY | -349.96% |
| 2023 Q2 | -434.25 Million CNY | -240.74% |
| 2023 Q1 | -127.44 Million CNY | 57.5% |
| 2022 Q3 | -602.19 Million CNY | -16.33% |
| 2022 Q2 | -517.65 Million CNY | 61.94% |
| 2022 Q1 | -1.36 Billion CNY | -466.9% |
| 2022 FY | -299.85 Million CNY | -180.89% |
| 2022 Q4 | -299.85 Million CNY | 50.21% |
| 2021 Q1 | 865.24 Million CNY | 507.39% |
| 2021 Q2 | -167.3 Million CNY | -119.34% |
| 2021 Q4 | 370.7 Million CNY | 106.87% |
| 2021 Q3 | 179.19 Million CNY | 207.11% |
| 2021 FY | 370.7 Million CNY | 274.54% |
| 2020 Q1 | -53.44 Million CNY | 0.0% |
| 2020 FY | -212.38 Million CNY | 23.79% |
| 2020 Q4 | -212.38 Million CNY | 0.0% |
| 2020 Q2 | -53.44 Million CNY | 0.0% |
| 2020 Q3 | -212.38 Million CNY | -297.39% |
| 2019 FY | -278.69 Million CNY | -94.87% |
| 2018 FY | -143.01 Million CNY | -437.92% |
| 2017 FY | -26.58 Million CNY | 0.0% |